Seno Medical’s Market-Ready Imagio® OA/US Breast Imaging System Receives Supplemental FDA PMA Approval
June 28, 2022 09:00 ET
|
Seno Medical
San Antonio, TX, June 28, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System, a revolutionary new modality in breast imaging, has received supplemental premarket approval (PMA)...
Edison Awards Program Honors Seno Medical’s Imagio® Breast Imaging System With a “Best of the Best” GOLD Award
April 25, 2022 10:00 ET
|
Seno Medical
San Antonio, TX, April 25, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System has been selected by the Edison Awards program as a GOLD award winner in the Science & Medical...
Seno Medical’s Imagio® Breast Imaging System Selected As GOLD Winner in Medical Device Excellence Awards
April 11, 2022 10:00 ET
|
Seno Medical
San Antonio, TX, April 11, 2022 (GLOBE NEWSWIRE) -- The 2022 Medical Device Excellence Awards program has selected Seno Medical’s Imagio® Breast Imaging System as a GOLD award winner in the...
Seno Medical’s Imagio® Breast Imaging System Named Finalist for Medical Device Excellence Awards
March 29, 2022 12:29 ET
|
Seno Medical
San Antonio, Texas, March 29, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological,...
Seno Medical’s Imagio® Breast Imaging System Named Finalist for Medical Device Excellence Awards
March 29, 2022 12:26 ET
|
Seno Medical
San Antonio, Texas, March 29, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological,...
Seno Medical’s Imagio® Breast Imaging System Named Science and Medical Category Finalist in 2022 Edison Awards Program
February 08, 2022 10:00 ET
|
Seno Medical
San Antonio, Texas, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category...
Poster Presentation at RSNA Compares Seno Medical’s OA/US Breast Imaging with AI Decision Support to Ultrasound Alone; Finds Significantly Better Specificity to Support Clinical Decision Making Confidence.
December 01, 2021 09:00 ET
|
Seno Medical
San Antonio, TX, Dec. 01, 2021 (GLOBE NEWSWIRE) -- A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s...
Seno Medical Launches CONFIDENCE Registry Study for Imagio® Breast Imaging System
October 21, 2021 11:00 ET
|
Seno Medical
San Antonio, TX, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Texas-based Seno Medical Instruments, Inc. (Seno) has launched its CONFIDENCE registry to evaluate the efficacy of imaging with...
FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
January 19, 2021 10:45 ET
|
Seno Medical
San Antonio, TX, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical...